Evidence map›Paper›PMID 42801400›Full record

ReviewMolecular biology reports2026

Resveratrol as a modulator of synaptic plasticity: molecular mechanisms and future therapeutic perspectives.

Amir Hossein Zarifkar, Sepideh Safaei

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amir Hossein ZarifkarDepartment of Basic Sciences, School of Medicine, Larestan University of Medical Sciences, Karmand St, North Ghadir Blvd, Larestan, 95639-74318, Iran. amirhosseinzarifkar13@yahoo.com.ORCID http://orcid.org/0000-0001-9094-538X
Sepideh SafaeiGerash Amir-al-Momenin Medical and Educational Center, Gerash University of Medical Sciences, Gerash, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol, a compound with polyphenolic properties, has been found in research to exhibit neuroprotective effects. By modulating signaling pathways associated with cell survival, apoptosis, and synaptic plasticity, Resveratrol holds the potential to mitigate cognitive decline. Particularly noteworthy is its ability to enhance hippocampal plasticity and adult hippocampal neurogenesis (AHN), both of which play critical roles in learning and memory. Synaptic plasticity refers to the ability of neuronal connections to strengthen or weaken based on their activity over time. Various types of cellular stress, such as oxidative stress, can induce apoptosis as a mechanism to maintain cellular equilibrium. Imbalances between the production and elimination of reactive oxygen species in the body give rise to oxidative stress. This imbalance can lead to neuronal damage and dysfunction, thereby impacting synaptic plasticity. The effect of resveratrol dosage determines its ability to either stimulate cellular proliferation or provoke cellular demise. Infinitesimal quantities of resveratrol have a beneficial effect on growth, while elevated doses have a detrimental effect on cell viability. Resveratrol possesses the capacity to eliminate reactive oxygen species (ROS) and mitigate the detrimental effects of oxidative stress. This review provides a synopsis of how resveratrol modulates synaptic plasticity pathways.

Indexed as

Neuronal PlasticityResveratrolAnimalsAntioxidantsApoptosisHippocampusHumansNeurogenesisNeuronsNeuroprotective AgentsOxidative StressReactive Oxygen SpeciesSignal TransductionAntioxidantsNeuroprotective AgentsReactive Oxygen SpeciesResveratrolHippocampusOxidative stressResveratrolROSSynaptic plasticity

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.